Our observation that RhoA kinase inhibition rapidly normalizes BP in the MLK3-KO mice demonstrates in vivo that disinhibition of RhoA is a major contributor to the hypertension in this model, and thus that MLK3 tonic inhibition of RhoA normally represses increases in BP. The gene discussed is MAP3K11; the disease is hypertensive disorder.